The Evolution of Human Female Sexual Orientation. Austin John Jeffery et al. [in press, Evolutionary Psychological Science, July 2018]. http://toddkshackelford.com/downloads/Jeffery-et-al-EPS.pdf
Abstract: Female sexual orientation has received less theoretical and empirical attention than male sexual orientation and few reviews are devoted to female sexual orientation. Moreover, research investigating female sexual orientation often underappreciates insights afforded by evolutionary theory. This review begins with an overview of the literature on female sexual identification, sexual perception, sexual fluidity, sexual expression, and the biology of female sexual orientation. Female same-sex sexual behaviors in the non-human apes are then described, providing a comparative context for the following discussion of hypotheses for the evolution of human female same-sex sexual attractions and behaviors. These hypotheses are organized as byproduct hypotheses or adaptation hypotheses and we include discussions of dysfunction, heterosis, sexual antagonism, epigenetics, weak selection, self-domestication, sexual frustration, mate attraction, alloparenting, polygyny, and other topics. We conclude by highlighting the challenges posed by evolutionary studies of human psychology.
Keywords: evolution, female homosexuality, female sexuality, sexual orientation
Thursday, August 23, 2018
Introduction of a machine translation system has significantly increased international trade on eBay, increasing exports by 17.5%; heterogeneous treatment effects are all consistent with a substantial reduction in translation-related search costs
Does Machine Translation Affect International Trade? Evidence from a Large Digital Platform. Erik Brynjolfsson, Xiang Hui, Meng Liu. NBER Working Paper No. 24917, Aug 2018. www.nber.org/papers/w24917
Abstract: Artificial intelligence (AI) is surpassing human performance in a growing number of domains. However, there is limited evidence of its economic effects. Using data from a digital platform, we study a key application of AI: machine translation. We find that the introduction of a machine translation system has significantly increased international trade on this platform, increasing exports by 17.5%. Furthermore, heterogeneous treatment effects are all consistent with a substantial reduction in translation-related search costs. Our results provide causal evidence that language barriers significantly hinder trade and that AI has already begun to improve economic efficiency in at least one domain.
Abstract: Artificial intelligence (AI) is surpassing human performance in a growing number of domains. However, there is limited evidence of its economic effects. Using data from a digital platform, we study a key application of AI: machine translation. We find that the introduction of a machine translation system has significantly increased international trade on this platform, increasing exports by 17.5%. Furthermore, heterogeneous treatment effects are all consistent with a substantial reduction in translation-related search costs. Our results provide causal evidence that language barriers significantly hinder trade and that AI has already begun to improve economic efficiency in at least one domain.
Physically attractive women had more intelligent husbands; a man's physical attractiveness was not associated with his wife’s intelligence; the results provide new information on cross-trait assortative mating
Cross-Trait Assortment for Intelligence and Physical Attractiveness. Curtis S. Dunkel et al. In press, Evolutionary Behavioral Sciences, July 2018. http://toddkshackelford.com/downloads/Dunkel-et-al-EBS.pdf
Abstract: We investigated cross-trait assortative mating for the traits of physical attractiveness and intelligence using data from the Wisconsin Longitudinal Study. It was hypothesized that more physically attractive individuals would have a spouse that was more intelligent, but that this association would be moderated by sex. Specifically, we predicted that more physically attractive women would have more intelligent husbands, but that a man’s physical attractiveness would not predict his wife’s intelligence. The results of correlation and regression analyses were consistent with these predictions, although the effect sizes were small. Additionally, we identified an interaction in which women’s physical attractiveness was more strongly associated with their husbands’ intelligence for more intelligent women than for less intelligent women. We conclude with suggestions for further research addressing cross-trait assortative mating for physical attractiveness and intelligence.
Abstract: We investigated cross-trait assortative mating for the traits of physical attractiveness and intelligence using data from the Wisconsin Longitudinal Study. It was hypothesized that more physically attractive individuals would have a spouse that was more intelligent, but that this association would be moderated by sex. Specifically, we predicted that more physically attractive women would have more intelligent husbands, but that a man’s physical attractiveness would not predict his wife’s intelligence. The results of correlation and regression analyses were consistent with these predictions, although the effect sizes were small. Additionally, we identified an interaction in which women’s physical attractiveness was more strongly associated with their husbands’ intelligence for more intelligent women than for less intelligent women. We conclude with suggestions for further research addressing cross-trait assortative mating for physical attractiveness and intelligence.
Exploring the Relationship Between Depression and Dementia
Exploring the Relationship Between Depression and Dementia. Rita Rubin. JAMA. Published online August 22, 2018. doi:10.1001/jama.2018.11154
Diagnosing and treating depression in people with mild cognitive impairment (MCI) or with dementia presents special challenges, but doing so can improve the quality of their lives as well as the lives of their caregivers and, in the case of MCI, might even delay progression to dementia.
Image description not available.
Researchers are still trying to tease out the relationship between depression and dementia. While depression does not appear to cause dementia, it likely is a risk factor, just as dementia is a risk factor for depression, said George Alexopoulos, MD, founder and director of the Weill-Cornell Institute of Geriatric Psychiatry. At least 20% of people with dementia develop a depressive syndrome, Alexopoulos said.
Often, though, the depression comes first. Some studies suggest that depression in early life is a risk factor for dementia, while depression later in life can be a prodrome of dementia, Alexopoulos said. Although findings are mixed, a 2014 review of the literature concluded that there is convincing evidence to suggest that depression can be a risk factor and a prodromal symptom of dementia.
In a more recent large longitudinal cohort study published in 2017 in JAMA Psychiatry, researchers followed the trajectory of depressive symptoms and dementia in 10 189 UK men and women over 28 years. Unlike some previous studies, this one found that depressive symptoms in midlife, even if chronic or recurring, were not associated with an increased risk of dementia. However, participants with depressive symptoms later in life had a higher risk of dementia. Depressive symptoms appear to be a prodromal feature of dementia or, perhaps, share common causes, such as neurodegeneration and inflammation, but they do not appear to increase the risk of dementia, according to the authors.
In contrast, another longitudinal study involving 4992 older Australian men, published 2 months earlier, found that those who had a history of depression earlier in life did have a higher risk of dementia than those who did not. However, the association was greater in men who were depressed when they entered the study. Treatment with antidepressants did not decrease the risk of depression-associated dementia, leading the authors to conclude that late-life depression should be considered an early sign of dementia, not a modifiable risk factor.
“Any time you have the first episode (of depression) at a later age, that’s always concerning for a neurodegenerative disorder,” said Anna Burke, MD, a geriatric psychiatrist and the director of neuropsychiatry at Barrow Neurological Institute in Phoenix, who was not involved with either study.
Raj Shah, MD, an associate professor of family medicine with the Rush University Alzheimer Disease Center in Chicago, recommends that a first episode of depression in older individuals be considered a sentinel event, the same way a fall is. Both events should spur questions about whether patients need to have their medication adjusted or whether the fall or the mood change is a marker of other conditions, Shah said.
Difficult Diagnosis
Depression is often overlooked when it accompanies dementia, Burke said.
“The problem is the DSM-5 [Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition)] criteria we use for major depressive disorder don’t necessarily fit for this population, much like in children, where depression presents differently,” she said.
As with children, adults living with dementia and depression might not talk about emotional pain or feeling down, Burke said. Instead, they might exhibit irritability—“they may just get a little more feisty,” she said—and an increase in somatic symptoms, such as aches and pains and gastrointestinal complaints.
“Sometimes people don’t get diagnosed with depression because there is such a huge overlap in symptoms between depression and dementia as well as growing older,” Burke said. Symptoms common to both depression and dementia include loss of interest in activities and hobbies, social withdrawal, and impaired thinking.
Because the symptoms overlap, caregivers might not recognize depression in people with dementia. “I’m often the first person to bring it up,” Burke said. “Even when people do seek treatment in the community, many physicians are not focused on treating anything beyond the memory changes. Nobody ever really discusses the behavioral changes, the changes in mood.”
Still, Alexopoulos said, “If you see the patient at the wrong time, you may miss it. Patients with dementia underreport depression, and caregivers are unreliable reporters.”
As David Steffens, MD, MHS, explained, “It’s hard to notice a change in mood when somebody can’t really voice how they’re feeling.”
But that doesn’t mean depression is insignificant in the setting of dementia. “One reason to treat depression is that depression makes underlying cognitive impairment much worse,” said Steffens, chairman of psychiatry at the University of Connecticut. “You want to give them their best cognitive chance.” Besides antidepressants, he said, psychiatrists have sometimes used electroconvulsive therapy to treat severe depression in people with mild dementia.
Drug Therapy
The prescribing of antidepressants to people with dementia appears to be increasing, according to a UK study published in 2017. Trends in diagnosis and treatment of people with dementia suggest that the proportion prescribed antidepressants rose from 28% to 36.6% from 2005 to 2015.
Antidepressants don’t seem to work as well in people with dementia, possibly because “depression in dementia is a different illness” than depression in people with normal cognition, Alexopoulos said. Cognitive control dysfunction in dementia appears to decrease the effectiveness of some selective serotonin reuptake inhibitors (SSRIs), he and his coauthors wrote in a 2015 article. “I think it is appropriate to try to treat with as little medication as you can,” in part because polypharmacy can lead to delirium syndromes in patients with dementia, Alexopoulos said.
Although the study of Australian men found that taking antidepressants did not reduce the risk of depression-associated dementia, recent research suggests that the drugs might slow the progression to dementia in people with MCI and depression. That study, published in 2017, found that taking the antidepressant citalopram (Celexa), an SSRI, for more than 4 years was associated with a delay in progression from MCI to Alzheimer disease by about 3 years. “Three years is a big deal in this age group,” Alexopoulos said. Experiments in mice and healthy humans have shown that citalopram reduces amyloid plaque, one of the hallmarks of Alzheimer disease.
Treating depression in people with MCI with antidepressants might slow the progression to dementia, but little is known about whether drugs and other interventions developed to treat Alzheimer disease have any effect on depression.
Most clinical trials of potential Alzheimer disease treatments do not consider neuropsychiatric symptoms such as depression or irritability as primary research targets, even though “these symptoms are widely recognized as the most stressful and challenging manifestations of dementia,” concluded authors of a recent review article. Only 17.7% of the relevant studies they found on clinicaltrials.gov tested the effect of pharmacological or nonpharmacological interventions on neuropsychiatric symptoms, they wrote.
Beyond Medication and Talk Therapy
People with MCI might still be able to benefit from cognitive behavioral therapy or psychotherapy, but that becomes less likely as they decline, Burke said. “A huge part of psychotherapy is being able to remember what happened in a session.”
Even individuals whose dementia is too advanced for talk therapy can still benefit from lifestyle changes, though, Burke said. Engaging them in social activities and modifying their environment to minimize triggers that make them anxious or irritable can help improve their quality of life, she said.
A recent pilot study suggested that increasing exposure to daylight can reduce depression in people with dementia. The 12-week study involved 77 people living in 8 dementia care communities. At 4 of the communities, staff took study participants to a room with windows for socialization from 8 am to 10 am each day. At the other 4 communities, staff took study participants to socialize in the mornings in a room illuminated only with typical artificial light.
At the end of the study, participants who had socialized in the rooms with daylight had a statistically significant decrease in their scores on the Cornell Scale for Depression in Dementia, while the other participants did not. More studies are needed to determine the appropriate timing, duration, wavelength, and intensity of light exposure for adults with dementia, the researchers concluded.
Another recent study suggested a perceived lack of social engagement is also associated with depressive symptoms in people with dementia. Researchers measured social engagement, medication use, and depressive symptoms in 402 community-dwelling adults whose average age was 86 years. The data were collected during the first interview at which the participants met the criteria for a dementia diagnosis. The researchers found a link between perceived social isolation and the severity of depressive symptoms but not between antidepressant use and severity of depressive symptoms.
Because the study participants were newly diagnosed, their dementia was mild to moderate. “At that stage, people can still engage,” coauthor Shah said. “If we break down some of the stigma around the diagnosis of dementia, it will help people build cultures of support and inclusiveness.”
Diagnosing and treating depression in people with mild cognitive impairment (MCI) or with dementia presents special challenges, but doing so can improve the quality of their lives as well as the lives of their caregivers and, in the case of MCI, might even delay progression to dementia.
Image description not available.
Researchers are still trying to tease out the relationship between depression and dementia. While depression does not appear to cause dementia, it likely is a risk factor, just as dementia is a risk factor for depression, said George Alexopoulos, MD, founder and director of the Weill-Cornell Institute of Geriatric Psychiatry. At least 20% of people with dementia develop a depressive syndrome, Alexopoulos said.
Often, though, the depression comes first. Some studies suggest that depression in early life is a risk factor for dementia, while depression later in life can be a prodrome of dementia, Alexopoulos said. Although findings are mixed, a 2014 review of the literature concluded that there is convincing evidence to suggest that depression can be a risk factor and a prodromal symptom of dementia.
In a more recent large longitudinal cohort study published in 2017 in JAMA Psychiatry, researchers followed the trajectory of depressive symptoms and dementia in 10 189 UK men and women over 28 years. Unlike some previous studies, this one found that depressive symptoms in midlife, even if chronic or recurring, were not associated with an increased risk of dementia. However, participants with depressive symptoms later in life had a higher risk of dementia. Depressive symptoms appear to be a prodromal feature of dementia or, perhaps, share common causes, such as neurodegeneration and inflammation, but they do not appear to increase the risk of dementia, according to the authors.
In contrast, another longitudinal study involving 4992 older Australian men, published 2 months earlier, found that those who had a history of depression earlier in life did have a higher risk of dementia than those who did not. However, the association was greater in men who were depressed when they entered the study. Treatment with antidepressants did not decrease the risk of depression-associated dementia, leading the authors to conclude that late-life depression should be considered an early sign of dementia, not a modifiable risk factor.
“Any time you have the first episode (of depression) at a later age, that’s always concerning for a neurodegenerative disorder,” said Anna Burke, MD, a geriatric psychiatrist and the director of neuropsychiatry at Barrow Neurological Institute in Phoenix, who was not involved with either study.
Raj Shah, MD, an associate professor of family medicine with the Rush University Alzheimer Disease Center in Chicago, recommends that a first episode of depression in older individuals be considered a sentinel event, the same way a fall is. Both events should spur questions about whether patients need to have their medication adjusted or whether the fall or the mood change is a marker of other conditions, Shah said.
Difficult Diagnosis
Depression is often overlooked when it accompanies dementia, Burke said.
“The problem is the DSM-5 [Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition)] criteria we use for major depressive disorder don’t necessarily fit for this population, much like in children, where depression presents differently,” she said.
As with children, adults living with dementia and depression might not talk about emotional pain or feeling down, Burke said. Instead, they might exhibit irritability—“they may just get a little more feisty,” she said—and an increase in somatic symptoms, such as aches and pains and gastrointestinal complaints.
“Sometimes people don’t get diagnosed with depression because there is such a huge overlap in symptoms between depression and dementia as well as growing older,” Burke said. Symptoms common to both depression and dementia include loss of interest in activities and hobbies, social withdrawal, and impaired thinking.
Because the symptoms overlap, caregivers might not recognize depression in people with dementia. “I’m often the first person to bring it up,” Burke said. “Even when people do seek treatment in the community, many physicians are not focused on treating anything beyond the memory changes. Nobody ever really discusses the behavioral changes, the changes in mood.”
Still, Alexopoulos said, “If you see the patient at the wrong time, you may miss it. Patients with dementia underreport depression, and caregivers are unreliable reporters.”
As David Steffens, MD, MHS, explained, “It’s hard to notice a change in mood when somebody can’t really voice how they’re feeling.”
But that doesn’t mean depression is insignificant in the setting of dementia. “One reason to treat depression is that depression makes underlying cognitive impairment much worse,” said Steffens, chairman of psychiatry at the University of Connecticut. “You want to give them their best cognitive chance.” Besides antidepressants, he said, psychiatrists have sometimes used electroconvulsive therapy to treat severe depression in people with mild dementia.
Drug Therapy
The prescribing of antidepressants to people with dementia appears to be increasing, according to a UK study published in 2017. Trends in diagnosis and treatment of people with dementia suggest that the proportion prescribed antidepressants rose from 28% to 36.6% from 2005 to 2015.
Antidepressants don’t seem to work as well in people with dementia, possibly because “depression in dementia is a different illness” than depression in people with normal cognition, Alexopoulos said. Cognitive control dysfunction in dementia appears to decrease the effectiveness of some selective serotonin reuptake inhibitors (SSRIs), he and his coauthors wrote in a 2015 article. “I think it is appropriate to try to treat with as little medication as you can,” in part because polypharmacy can lead to delirium syndromes in patients with dementia, Alexopoulos said.
Although the study of Australian men found that taking antidepressants did not reduce the risk of depression-associated dementia, recent research suggests that the drugs might slow the progression to dementia in people with MCI and depression. That study, published in 2017, found that taking the antidepressant citalopram (Celexa), an SSRI, for more than 4 years was associated with a delay in progression from MCI to Alzheimer disease by about 3 years. “Three years is a big deal in this age group,” Alexopoulos said. Experiments in mice and healthy humans have shown that citalopram reduces amyloid plaque, one of the hallmarks of Alzheimer disease.
Treating depression in people with MCI with antidepressants might slow the progression to dementia, but little is known about whether drugs and other interventions developed to treat Alzheimer disease have any effect on depression.
Most clinical trials of potential Alzheimer disease treatments do not consider neuropsychiatric symptoms such as depression or irritability as primary research targets, even though “these symptoms are widely recognized as the most stressful and challenging manifestations of dementia,” concluded authors of a recent review article. Only 17.7% of the relevant studies they found on clinicaltrials.gov tested the effect of pharmacological or nonpharmacological interventions on neuropsychiatric symptoms, they wrote.
Beyond Medication and Talk Therapy
People with MCI might still be able to benefit from cognitive behavioral therapy or psychotherapy, but that becomes less likely as they decline, Burke said. “A huge part of psychotherapy is being able to remember what happened in a session.”
Even individuals whose dementia is too advanced for talk therapy can still benefit from lifestyle changes, though, Burke said. Engaging them in social activities and modifying their environment to minimize triggers that make them anxious or irritable can help improve their quality of life, she said.
A recent pilot study suggested that increasing exposure to daylight can reduce depression in people with dementia. The 12-week study involved 77 people living in 8 dementia care communities. At 4 of the communities, staff took study participants to a room with windows for socialization from 8 am to 10 am each day. At the other 4 communities, staff took study participants to socialize in the mornings in a room illuminated only with typical artificial light.
At the end of the study, participants who had socialized in the rooms with daylight had a statistically significant decrease in their scores on the Cornell Scale for Depression in Dementia, while the other participants did not. More studies are needed to determine the appropriate timing, duration, wavelength, and intensity of light exposure for adults with dementia, the researchers concluded.
Another recent study suggested a perceived lack of social engagement is also associated with depressive symptoms in people with dementia. Researchers measured social engagement, medication use, and depressive symptoms in 402 community-dwelling adults whose average age was 86 years. The data were collected during the first interview at which the participants met the criteria for a dementia diagnosis. The researchers found a link between perceived social isolation and the severity of depressive symptoms but not between antidepressant use and severity of depressive symptoms.
Because the study participants were newly diagnosed, their dementia was mild to moderate. “At that stage, people can still engage,” coauthor Shah said. “If we break down some of the stigma around the diagnosis of dementia, it will help people build cultures of support and inclusiveness.”
We assigned endowments to individuals who could spend all or part of those endowments on a charitable donation; consistent with our hypothesis, subjects may engage in charitable giving to signal their smarts
Giving to Charity to Signal Smarts Evidence from a Lab Experiment. Felipe Montano, Ricardo Perez-Truglia. Journal of Behavioral and Experimental Economics, https://doi.org/10.1016/j.socec.2018.08.004
Highlights
• We propose individuals give to charity to signal smarts.
• We designed a laboratory experiment to test this hypothesis.
• Individuals have to donate out of an endowment.
• We randomize the publicity of the donation.
• We randomize if the endowments are distributed at random or according to intelligence.
• We find suggestive evidence that donations are used to signal smarts.
Abstract: The literature on charitable giving suggests that individuals may use their charitable donations to signal their altruism or their income. We argue that, rather than signaling income per se, individuals may want to signal other unobservable characteristics that correlate to income, such as their intelligence. We designed a laboratory experiment to test this hypothesis. We assigned endowments to individuals who could spend all or part of those endowments on a charitable donation. We cross-randomized the visibility of donations and the individuals’ perceptions about the effect of intelligence on the allocation of endowments. We found that the effect of donation visibility on donation amounts depends sharply on whether the individuals perceive that endowments are determined by intelligence. This evidence suggests that, consistent with our hypothesis, subjects may engage in charitable giving to signal their smarts.
Highlights
• We propose individuals give to charity to signal smarts.
• We designed a laboratory experiment to test this hypothesis.
• Individuals have to donate out of an endowment.
• We randomize the publicity of the donation.
• We randomize if the endowments are distributed at random or according to intelligence.
• We find suggestive evidence that donations are used to signal smarts.
Abstract: The literature on charitable giving suggests that individuals may use their charitable donations to signal their altruism or their income. We argue that, rather than signaling income per se, individuals may want to signal other unobservable characteristics that correlate to income, such as their intelligence. We designed a laboratory experiment to test this hypothesis. We assigned endowments to individuals who could spend all or part of those endowments on a charitable donation. We cross-randomized the visibility of donations and the individuals’ perceptions about the effect of intelligence on the allocation of endowments. We found that the effect of donation visibility on donation amounts depends sharply on whether the individuals perceive that endowments are determined by intelligence. This evidence suggests that, consistent with our hypothesis, subjects may engage in charitable giving to signal their smarts.
Women not using the contraceptive pill (naturally cycling women) reported spending more time applying cosmetics than did women who use the contraceptive pill; the faces of these naturally cycling women were rated as wearing more cosmetics
Evidence That the Hormonal Contraceptive Pill Is Associated With Cosmetic Habits. Carlota Batres et al. Front. Psychol., Aug 23 2018, https://doi.org/10.3389/fpsyg.2018.01459
Abstract: Hormonal contraception is known to cause subtle but widespread behavioral changes. Here, we investigated whether changes in cosmetic habits are associated with use of the hormonal contraceptive pill. We photographed a sample of women (N = 36) who self-reported whether or not they use the contraceptive pill, as well as their cosmetic habits. A separate sample of participants (N = 143) rated how much makeup these target women appeared to be wearing. We found that women not using the contraceptive pill (i.e., naturally cycling women) reported spending more time applying cosmetics for an outing than did women who use the contraceptive pill. We also found that the faces of these naturally cycling women were rated as wearing more cosmetics than the faces of the women using the contraceptive pill. Thus, we found clear associations between contraceptive pill use and makeup use. This provides evidence consistent with the possibility that cosmetic habits, and grooming behaviors more generally, are affected by hormonal contraception.
Abstract: Hormonal contraception is known to cause subtle but widespread behavioral changes. Here, we investigated whether changes in cosmetic habits are associated with use of the hormonal contraceptive pill. We photographed a sample of women (N = 36) who self-reported whether or not they use the contraceptive pill, as well as their cosmetic habits. A separate sample of participants (N = 143) rated how much makeup these target women appeared to be wearing. We found that women not using the contraceptive pill (i.e., naturally cycling women) reported spending more time applying cosmetics for an outing than did women who use the contraceptive pill. We also found that the faces of these naturally cycling women were rated as wearing more cosmetics than the faces of the women using the contraceptive pill. Thus, we found clear associations between contraceptive pill use and makeup use. This provides evidence consistent with the possibility that cosmetic habits, and grooming behaviors more generally, are affected by hormonal contraception.
Is an amygdala necessary to experience and perceive fear? One potential mechanism for not perceiving fear is a failure to spontaneously attend to widened eyes, the most distinctive physical feature portrayed in symbolic fear expressions
Seeing Fear: It’s All in the Eyes? Lisa Feldman Barrett. Trends in Neurosciences, Volume 41, Issue 9, September 2018, Pages 559-563. https://doi.org/10.1016/j.tins.2018.06.009
Abstract: Is an amygdala necessary to experience and perceive fear? Intriguing evidence comes from patient S.M. who lost her left and right amygdalae to disease. Initial testing suggested that S.M.’s most defining symptom was an inability to recognize fear in other people’s facial expressions. A fascinating paper by Adolphs and colleagues in 2005 examined one potential mechanism for this impairment: a failure to spontaneously attend to widened eyes, the most distinctive physical feature portrayed in symbolic fear expressions. This study helped to invigorate debates about the brain basis of fear and paved the way for a more nuanced understanding of amygdalar function.
Abstract: Is an amygdala necessary to experience and perceive fear? Intriguing evidence comes from patient S.M. who lost her left and right amygdalae to disease. Initial testing suggested that S.M.’s most defining symptom was an inability to recognize fear in other people’s facial expressions. A fascinating paper by Adolphs and colleagues in 2005 examined one potential mechanism for this impairment: a failure to spontaneously attend to widened eyes, the most distinctive physical feature portrayed in symbolic fear expressions. This study helped to invigorate debates about the brain basis of fear and paved the way for a more nuanced understanding of amygdalar function.
Subscribe to:
Posts (Atom)
Posts
